ERBA Diagnostics up 30% on cash infusion from German parent

Stock Information for ERBA Diagnostics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ERBA Diagnostics Inc.

ERBA Diagnostics to Commence Trading on OTC Markets' Pink Open Market After Delisting by the NYSE MKT
ERBA Diagnostics, Inc. Announces Inability to Meet Deadline to Regain Compliance With NYSE MKT Continued Listing Standards
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
ERBA Diagnostics, Inc. Announces Extension of CEO'S Contract Term and Appointment of Hayden Jeffreys to Board of Directors
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards and Extension of Compliance Plan
ERBA Diagnostics, Inc. Announces Notice of Noncompliance With NYSE MKT Continued Listing Standards
SHAREHOLDER ALERT: ERBA Diagnostics, Inc. ("ERB") is the Subject of a Legal Investigation
DEADLINE TODAY: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.